Laboratory-Acquired Severe Acute Respiratory Syndrome

New England Journal of Medicine

Volumn 350, Issue 17, 2004, Pages 1740-1745

  Lim, Poh Lian ^a   Kurup, Asok ^b   Gopalakrishna, Gowri ^c   Chan, Kwai Peng ^b   Wong, Christopher W ^d   Ng, Lee Ching ^e   Se Thoe, Su Yun ^b   Oon, Lynette ^b   Bai, Xinlai ^b   Stanton, Lawrence W ^d   Ruan, Yijun ^d   Miller, Lance D ^d   Vega, Vinsensius B ^d   James, Lyn ^c   Ooi, Peng Lim ^c   Kai, Chew Suok ^c   Olsen, Sonja J ^f   Ang, Brenda ^a   Leo, Yee Sin ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c MINISTRY OF HEALTH   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

^e DSO NATIONAL LABORATORIES   (Singapore)

^f Centers for Disease Control CDC Thailand Field Station   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; HUMAN; LABORATORY TEST; LUNG INFILTRATE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATOLOGY; VIRUS CULTURE;

ADULT; BIOMEDICAL RESEARCH; DNA, VIRAL; GENOME, VIRAL; HUMANS; LABORATORIES; LABORATORY PERSONNEL; MALE; OCCUPATIONAL DISEASES; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARS VIRUS; SEQUENCE ANALYSIS, DNA; SEVERE ACUTE RESPIRATORY SYNDROME; SINGAPORE;

EID: 4444302913     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032565     Document Type: Review

References (20)

1. Centers for Disease Control and Prevention. Travel alert removed. Singapore. (Accessed March 26, 2004, at http://www.cdc. gov/travel/other/sarssingapore.htm.)
2. Idem. SARS information for travelers: February 11, 2004. (Accessed March 26, 2004, at http://www.cdc.gov/ncidod/sars/travel.htm.)
3. Ng LFP, Wong M, Koh S, et al. Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. J Clin Microbiol 2004;42:347-50.
4. Research, therapy and training in tropical medicine: centenary of the tropical institute. Hamburg, Germany: Bernhard-Nocht-Institute of Tropical Medicine, 2000. (Accessed March 26, 2004 at http://www. bni-hamburg.de.)
5. Shi PY, Kauffman EB, Ren P, et al. High-throughput detection of West Nile virus RNA. J Clin Microbiol 2001;39:1264-71.
6. Scaramozzino N, Crance JM, Jouan A, DeBriel DA, Stoll F, Garin D. Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences. J Clin Microbiol 2001;39:1922-7.
7. Wong CW, Albert TJ, Vega VB, et al. Tracking the evolution of the SARS coronavirus using rapid, high-throughput, high-density resequencing arrays. Genome Res 2004;14:398-405.
8. Ruan YJ, Wei CL, Fe AL, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-85. [Erratum, Lancet 2003;361:1832.]
9. Ruan YJ, Wei CL, Fe AL, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-85. [Erratum, Lancet 2003;361:1832.]
10. Centers for Disease Control and Prevention. Updated interim U.S. case definition for severe acute respiratory syndrome (SARS). (Accessed March 26, 2004, at http://www. cdc.gov/ncidod/sars/casedefinition.htm.)
11. Swofford DL. PAUP: phylogenetic analysis using parsimony (and other methods), version 4.0. Sunderland, Mass.: Sinauer, 2002.
12. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [Erratum, JAMA 2003;290:334.]
13. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9. [Erratum, JAMA 2003;290:334.]
14. Hsu L-Y, Lee C-C, Green JA, et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003;9:713-7.
15. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
16. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000;38:4066-71.
17. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361:1519-20.
18. Laboratory-acquired West Nile virus infections - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:1133-5.
19. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). (Accessed March 26, 2004, at http://www.who.int/csr/sars/casedefinition/en.)
20. Biosafety and SARS incident in Singapore September 2003: report of the Review Panel on New SARS Case and Biosafety. Singapore: Ministry of Health, 2003. (Accessed March 26, 2004, at http://www.moh. gov.sg/sars/advisories/default.html.)